Work

First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non–Small-Cell Lung Cancer

Year: 2020

Type: article

Study design: Clinical Trial

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2020.07.001

Authors: Jing Zheng, Lisha Shen, Nan Jiang, Yanping Zhu, Lihua Wu, He Cao, Wenjia Sun, Jianya Zhou, Jianying Zhou

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Key Research and Development Program of Zhejiang Province

Award: G6354677086

OpenAlex ID: W3040766773

FWCI: 0.237

Cites: 31

Cited by: 6

Related to: 10